CNCE
Concert Pharmaceuticals, Inc.
CNCE
CNCE
Delisted
CNCE was delisted on the 3rd of March, 2023.
93 hedge funds and large institutions have $222M invested in Concert Pharmaceuticals, Inc. in 2018 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 27 increasing their positions, 42 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less call options, than puts
Call options by funds: $ | Put options by funds: $
67% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 27
Holders
93
Holding in Top 10
–
Calls
$176K
Puts
$432K
Top Buyers
| 1 | +$22.8M | |
| 2 | +$9.9M | |
| 3 | +$6.08M | |
| 4 |
Millennium Management
New York
|
+$5.92M |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$1.33M |
Top Sellers
| 1 | -$5.54M | |
| 2 | -$4.42M | |
| 3 | -$3.43M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$3.03M |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$2.62M |